Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 747

1.

A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.

Myrehaug S, Chan G, Craig T, Weinberg V, Cheng C, Roach M 3rd, Cheung P, Sahgal A.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e657-62. doi: 10.1016/j.ijrobp.2011.09.006. Epub 2012 Jan 13.

PMID:
22245189
[PubMed - indexed for MEDLINE]
2.

A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.

Pasquier D, Cavillon F, Lacornerie T, Touzeau C, Tresch E, Lartigau E.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):549-54. doi: 10.1016/j.ijrobp.2012.03.046. Epub 2012 Jun 5.

PMID:
22677369
[PubMed - indexed for MEDLINE]
3.

Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.

Yoo S, Wu QJ, Lee WR, Yin FF.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):935-42. doi: 10.1016/j.ijrobp.2009.07.1677. Epub 2010 Jan 8.

PMID:
20044214
[PubMed - indexed for MEDLINE]
4.

Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.

Malone S, Croke J, Roustan-Delatour N, Belanger E, Avruch L, Malone C, Morash C, Kayser C, Underhill K, Li Y, Malone K, Nyiri B, Spaans J.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):725-32. doi: 10.1016/j.ijrobp.2011.12.081. Epub 2012 Mar 22.

PMID:
22444999
[PubMed - indexed for MEDLINE]
5.

Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.

Hong TS, Tomé WA, Jaradat H, Raisbeck BM, Ritter MA.

Acta Oncol. 2006;45(6):717-27.

PMID:
16938815
[PubMed - indexed for MEDLINE]
6.

Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.

Metwaly M, Awaad AM, El-Sayed el-SM, Sallam AS.

J Appl Clin Med Phys. 2008 Oct 24;9(4):2783.

PMID:
19020481
[PubMed - indexed for MEDLINE]
7.

Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.

Arcangeli S, Saracino B, Petrongari MG, Gomellini S, Marzi S, Landoni V, Gallucci M, Sperduti I, Arcangeli G.

Radiother Oncol. 2007 Aug;84(2):148-55. Epub 2007 Aug 9.

PMID:
17692416
[PubMed - indexed for MEDLINE]
8.

Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.

Lim TS, Cheung PC, Loblaw DA, Morton G, Sixel KE, Pang G, Basran P, Zhang L, Tirona R, Szumacher E, Danjoux C, Choo R, Thomas G.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):85-92. doi: 10.1016/j.ijrobp.2007.12.041. Epub 2008 Mar 20.

PMID:
18355982
[PubMed - indexed for MEDLINE]
9.

Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.

Abbas AS, Moseley D, Kassam Z, Kim SM, Cho C.

J Appl Clin Med Phys. 2013 May 6;14(3):4269. doi: 10.1120/jacmp.v14i3.4269.

PMID:
23652258
[PubMed - indexed for MEDLINE]
10.

Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer.

Meijer HJ, Debats OA, Kunze-Busch M, van Kollenburg P, Leer JW, Witjes JA, Kaanders JH, Barentsz JO, van Lin EN.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):175-83. doi: 10.1016/j.ijrobp.2010.09.023. Epub 2010 Nov 13.

PMID:
21075555
[PubMed - indexed for MEDLINE]
11.

Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.

Chera BS, Vargas C, Morris CG, Louis D, Flampouri S, Yeung D, Duvvuri S, Li Z, Mendenhall NP.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):994-1002. doi: 10.1016/j.ijrobp.2009.01.044. Epub 2009 Jul 18.

PMID:
19619961
[PubMed - indexed for MEDLINE]
12.

Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.

Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):763-72. doi: 10.1016/j.ijrobp.2009.08.043. Epub 2010 Feb 18.

PMID:
20171807
[PubMed - indexed for MEDLINE]
13.

Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer. Report of feasibility and acute toxicity.

Alongi F, Fogliata A, Navarria P, Tozzi A, Mancosu P, Lobefalo F, Reggiori G, Clivio A, Cozzi L, Scorsetti M.

Strahlenther Onkol. 2012 Nov;188(11):990-6. doi: 10.1007/s00066-012-0171-7. Epub 2012 Sep 29.

PMID:
23053143
[PubMed - indexed for MEDLINE]
14.

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.

Fonteyne V, De Gersem W, De Neve W, Jacobs F, Lumen N, Vandecasteele K, Villeirs G, De Meerleer G.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1013-20. doi: 10.1016/j.ijrobp.2008.12.047. Epub 2009 Apr 20.

PMID:
19386427
[PubMed - indexed for MEDLINE]
15.

Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.

Ng M, Leong T, Chander S, Chu J, Kneebone A, Carroll S, Wiltshire K, Ngan S, Kachnic L.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1455-62. doi: 10.1016/j.ijrobp.2011.12.058. Epub 2012 Mar 6.

PMID:
22401917
[PubMed - indexed for MEDLINE]
16.

Simultaneous integrated boost plan comparison of volumetric-modulated arc therapy and sliding window intensity-modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer.

Riou O, Regnault de la Mothe P, Azria D, Aillères N, Dubois JB, Fenoglietto P.

J Appl Clin Med Phys. 2013 Jul 8;14(4):4094. doi: 10.1120/jacmp.v14i4.4094.

PMID:
23835376
[PubMed - indexed for MEDLINE]
17.

Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique.

Ganswindt U, Paulsen F, Corvin S, Hundt I, Alber M, Frey B, Stenzl A, Bares R, Bamberg M, Belka C.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):347-55.

PMID:
17236960
[PubMed - indexed for MEDLINE]
18.

Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.

McCammon R, Rusthoven KE, Kavanagh B, Newell S, Newman F, Raben D.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):413-20. doi: 10.1016/j.ijrobp.2008.10.050. Epub 2009 Apr 11.

PMID:
19362783
[PubMed - indexed for MEDLINE]
19.

Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer.

Pasler M, Georg D, Wirtz H, Lutterbach J.

Strahlenther Onkol. 2011 Dec;187(12):792-8. doi: 10.1007/s00066-011-1150-0. Epub 2011 Nov 29.

PMID:
22127357
[PubMed - indexed for MEDLINE]
20.

Dose comparisons for conformal, IMRT and VMAT prostate plans.

Sale C, Moloney P.

J Med Imaging Radiat Oncol. 2011 Dec;55(6):611-21. doi: 10.1111/j.1754-9485.2011.02310.x.

PMID:
22141609
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk